• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    More On NRT.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Novogen Limited (NRT.AX)

    -ASX
    0.18 Up 0.05(38.46%) 12:10AM EST
    Add to Portfolio
    Prev Close:0.13
    Open:0.19
    Bid:0.18
    Ask:0.18
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.17 - 0.24
    52wk Range:0.12 - 0.40
    Volume:50,672,489
    Avg Vol (3m):N/A
    Market Cap:45.00M
    P/E (ttm):N/A
    EPS (ttm):-0.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback